REFERENCES
1 Meier, R. K. Polycystic Ovary Syndrome. The Nursing clinics of North America 53 , 407-420, doi:10.1016/j.cnur.2018.04.008 (2018).
2 Lizneva, D., Suturina, L., Walker, W., Brakta, S., Gavrilova-Jordan, L. & Azziz, R. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertility and Sterility 106 , 6-15, doi:10.1016/j.fertnstert.2016.05.003 (2016).
3 ACOG Practice Bulletin No. 194: Polycystic Ovary Syndrome.Obstetrics and gynecology 131 , e157-e171, doi:10.1097/aog.0000000000002656 (2018).
4 Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S., Legro, R. S. et al. Polycystic ovary syndrome. Nat Rev Dis Primers2 , 16057, doi:10.1038/nrdp.2016.57 (2016).
5 Cela, V., Obino, M. E. R., Alberga, Y., Pinelli, S., Sergiampietri, C., Casarosa, E. et al. Ovarian response to controlled ovarian stimulation in women with different polycystic ovary syndrome phenotypes. Gynecol Endocrinol 34 , 518-523, doi:10.1080/09513590.2017.1412429 (2018).
6 Ramezanali, F., Ashrafi, M., Hemat, M., Arabipoor, A., Jalali, S. & Moini, A. Assisted reproductive outcomes in women with different polycystic ovary syndrome phenotypes: the predictive value of anti-Mullerian hormone. Reprod Biomed Online 32 , 503-512, doi:10.1016/j.rbmo.2016.01.010 (2016).
7 Tal, R., Seifer, D. B., Khanimov, M., Malter, H. E., Grazi, R. V. & Leader, B. Characterization of women with elevated antimullerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes. Am J Obstet Gynecol 211 , 59, e51-e58, doi:10.1016/j.ajog.2014.02.026 (2014).
8 Mourad, S., Brown, J. & Farquhar, C. Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews. The Cochrane database of systematic reviews 1 , Cd012103, doi:10.1002/14651858.CD012103.pub2 (2017).
9 Blumenfeld, Z. The Ovarian Hyperstimulation Syndrome. Vitam Horm 107 , 423-451, doi:10.1016/bs.vh.2018.01.018 (2018).
10 Roque, M., Haahr, T., Geber, S., Esteves, S. C. & Humaidan, P. Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes. Hum Reprod Update 25 , 2-14, doi:10.1093/humupd/dmy033 (2019).
11 Chen, Z. J., Shi, Y., Sun, Y., Zhang, B., Liang, X., Cao, Y. et al. Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary Syndrome. The New England journal of medicine 375 , 523-533, doi:10.1056/NEJMoa1513873 (2016).
12 Singh, B., Reschke, L., Segars, J. & Baker, V. L. Frozen-thawed embryo transfer: the potential importance of the corpus luteum in preventing obstetrical complications. Fertil Steril 113 , 252-257, doi:10.1016/j.fertnstert.2019.12.007 (2020).
13 Roos, N., Kieler, H., Sahlin, L., Ekman-Ordeberg, G., Falconer, H. & Stephansson, O. Risk of adverse pregnancy outcomes in women with polycystic ovary syndrome: population based cohort study. Bmj343 , d6309, doi:10.1136/bmj.d6309 (2011).
14 Palomba, S., de Wilde, M. A., Falbo, A., Koster, M. P., La Sala, G. B. & Fauser, B. C. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update 21 , 575-592, doi:10.1093/humupd/dmv029 (2015).
15 Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility81 , 19-25, doi:10.1016/j.fertnstert.2003.10.004 (2004).
16 Norman, R. J., Dewailly, D., Legro, R. S. & Hickey, T. E. Polycystic ovary syndrome. The Lancet 370 , 685-697, doi:10.1016/s0140-6736(07)61345-2 (2007).
17 Qiu, M., Tao, Y., Kuang, Y. & Wang, Y. Effect of body mass index on pregnancy outcomes with the freeze-all strategy in women with polycystic ovarian syndrome. Fertil Steril 112 , 1172-1179, doi:10.1016/j.fertnstert.2019.08.009 (2019).
18 Sun, Y. F., Zhang, J., Xu, Y. M., Cao, Z. Y., Wang, Y. Z., Hao, G. M.et al. High BMI and Insulin Resistance Are Risk Factors for Spontaneous Abortion in Patients With Polycystic Ovary Syndrome Undergoing Assisted Reproductive Treatment: A Systematic Review and Meta-Analysis. Frontiers in endocrinology 11 , 592495, doi:10.3389/fendo.2020.592495 (2020).
19 Zhang, Y., Zhao, W., Xu, H., Hu, M., Guo, X., Jia, W. et al.Hyperandrogenism and insulin resistance-induced fetal loss: evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome. The Journal of physiology597 , 3927-3950, doi:10.1113/jp277879 (2019).
20 Song, J., Wang, X., Guo, Y., Yang, Y., Xu, K., Wang, T. et al.Novel high-coverage targeted metabolomics method (SWATHtoMRM) for exploring follicular fluid metabolome alterations in women with recurrent spontaneous abortion undergoing in vitro fertilization.Scientific reports 9 , 10873, doi:10.1038/s41598-019-47370-7 (2019).
21 Legro, R. S. Pregnancy considerations in women with polycystic ovary syndrome. Clin Obstet Gynecol 50 , 295-304, doi:10.1097/GRF.0b013e31803057ed (2007).
22 van der Spuy, Z. M. & Dyer, S. J. The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18 , 755-771, doi:10.1016/j.bpobgyn.2004.06.001 (2004).
23 Yu, H. F., Chen, H. S., Rao, D. P. & Gong, J. Association between polycystic ovary syndrome and the risk of pregnancy complications: A PRISMA-compliant systematic review and meta-analysis. Medicine95 , e4863, doi:10.1097/md.0000000000004863 (2016).
24 Zehravi, M., Maqbool, M. & Ara, I. Polycystic ovary syndrome and reproductive health of women: a curious association. International journal of adolescent medicine and health , doi:10.1515/ijamh-2021-0031 (2021).
25 Wang, J. X., Norman, R. J. & Wilcox, A. J. Incidence of spontaneous abortion among pregnancies produced by assisted reproductive technology.Hum Reprod 19 , 272-277, doi:10.1093/humrep/deh078 (2004).
26 Barnes, F. L., Kausche, A., Tiglias, J., Wood, C., Wilton, L. & Trounson, A. Production of embryos from in vitro-matured primary human oocytes. Fertil Steril 65 , 1151-1156, doi:10.1016/s0015-0282(16)58330-7 (1996).
27 Santos, J. E., Bisinotto, R. S. & Ribeiro, E. S. Mechanisms underlying reduced fertility in anovular dairy cows.Theriogenology 86 , 254-262, doi:10.1016/j.theriogenology.2016.04.038 (2016).
28 Jia, L., Li, J., He, B., Jia, Y., Niu, Y., Wang, C. et al.Abnormally activated one-carbon metabolic pathway is associated with mtDNA hypermethylation and mitochondrial malfunction in the oocytes of polycystic gilt ovaries. Scientific reports 6 , 19436, doi:10.1038/srep19436 (2016).
29 Aslih, N., Dorzia, D., Atzmon, Y., Estrada, D., Ellenbogen, A., Bilgory, A. et al. Ovulatory-Based FET Cycles May Achieve Higher Pregnancy Rates in the General Population and among Anovulatory Women.Journal of clinical medicine 10 , doi:10.3390/jcm10040703 (2021).
30 Xu, H., Qiu, S., Chen, X., Zhu, S., Sun, Y. & Zheng, B. D6 blastocyst transfer on day 6 in frozen-thawed cycles should be avoided: a retrospective cohort study. BMC Pregnancy Childbirth20 , 519, doi:10.1186/s12884-020-03224-z (2020).
31 Cerrillo, M., Herrero, L., Guillén, A., Mayoral, M. & García-Velasco, J. A. Impact of Endometrial Preparation Protocols for Frozen Embryo Transfer on Live Birth Rates. Rambam Maimonides medical journal 8 , doi:10.5041/rmmj.10297 (2017).
32 Liu, X., Shi, W. & Shi, J. Natural cycle frozen-thawed embryo transfer in young women with regular menstrual cycles increases the live-birth rates compared with hormone replacement treatment: a retrospective cohort study. Fertil Steril 113 , 811-817, doi:10.1016/j.fertnstert.2019.11.023 (2020).
33 Patel, S., Kilburn, B., Imudia, A., Armant, D. R. & Skafar, D. F. Estradiol Elicits Proapoptotic and Antiproliferative Effects in Human Trophoblast Cells. Biol Reprod 93 , 74, doi:10.1095/biolreprod.115.129114 (2015).
34 Hancke, K., More, S., Kreienberg, R. & Weiss, J. M. Patients undergoing frozen-thawed embryo transfer have similar live birth rates in spontaneous and artificial cycles. J Assist Reprod Genet29 , 403-407, doi:10.1007/s10815-012-9724-z (2012).
35 Talmor, A. & Dunphy, B. Female obesity and infertility. Best Pract Res Clin Obstet Gynaecol 29 , 498-506, doi:10.1016/j.bpobgyn.2014.10.014 (2015).
36 Metwally, M., Ong, K. J., Ledger, W. L. & Li, T. C. Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence. Fertil Steril 90 , 714-726, doi:10.1016/j.fertnstert.2007.07.1290 (2008).
37 Bellver, J., Rossal, L. P., Bosch, E., Zúñiga, A., Corona, J. T., Meléndez, F. et al. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril 79 , 1136-1140, doi:10.1016/s0015-0282(03)00176-6 (2003).
38 Zhou, H., Zhang, D., Luo, Z., Yang, A., Cui, N., Hao, G. et al. Association between Body Mass Index and Reproductive Outcome in Women with Polycystic Ovary Syndrome Receiving IVF/ICSI-ET. BioMed research international 2020 , 6434080, doi:10.1155/2020/6434080 (2020).
39 Metwally, M., Cutting, R., Tipton, A., Skull, J., Ledger, W. L. & Li, T. C. Effect of increased body mass index on oocyte and embryo quality in IVF patients. Reprod Biomed Online 15 , 532-538, doi:10.1016/s1472-6483(10)60385-9 (2007).
40 Li, X., Ding, W., Liu, J. Y., Mao, Y. D., Huang, J., Wang, W.et al. [Effects of dyslipidemia on IVF/ICSI pregnancy outcome in patients with polycystic ovary syndrome]. Zhonghua Fu Chan Ke Za Zhi 53 , 402-408, doi:10.3760/cma.j.issn.0529-567x.2018.06.008 (2018).
41 Lee, Y. S., Biddle, S., Chan, M. F., Cheng, A., Cheong, M., Chong, Y. S. et al. Health Promotion Board-Ministry of Health Clinical Practice Guidelines: Obesity. Singapore medical journal57 , 472, doi:10.11622/smedj.2016141 (2016).
42 Magnus, M. C., Wilcox, A. J., Morken, N. H., Weinberg, C. R. & Håberg, S. E. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. Bmj 364 , l869, doi:10.1136/bmj.l869 (2019).
43 du Fossé, N. A., van der Hoorn, M. P., van Lith, J. M. M., le Cessie, S. & Lashley, E. Advanced paternal age is associated with an increased risk of spontaneous miscarriage: a systematic review and meta-analysis.Hum Reprod Update 26 , 650-669, doi:10.1093/humupd/dmaa010 (2020).
44 Li, J., Liu, X., Hu, L., Zhang, F., Wang, F., Kong, H. et al.A Slower Age-Related Decline in Treatment Outcomes After the First Ovarian Stimulation for in vitro Fertilization in Women With Polycystic Ovary Syndrome. Frontiers in endocrinology 10 , 834, doi:10.3389/fendo.2019.00834 (2019).
45 Weghofer, A., Munne, S., Chen, S., Barad, D. & Gleicher, N. Lack of association between polycystic ovary syndrome and embryonic aneuploidy.Fertil Steril 88 , 900-905, doi:10.1016/j.fertnstert.2006.12.018 (2007).
46 Yang, W., Yang, R., Yang, S., Li, J., Tu, B., Gao, C. et al.Infertile polycystic ovary syndrome patients undergoing in vitro fertilization with the gonadotropin-releasing hormone-antagonist protocol: role of hyperandrogenism. Gynecol Endocrinol34 , 715-718, doi:10.1080/09513590.2018.1431773 (2018).
Table 1. Baseline characteristics and ovarian responses of four PCOS phenotype and control groups